Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jihyoun | - |
dc.contributor.author | Alqudaihi, Heba M. | - |
dc.contributor.author | Kang, Michael Seungcheol | - |
dc.contributor.author | Kim, Jisun | - |
dc.contributor.author | Lee, Jong Won | - |
dc.contributor.author | Ko, Beom Seok | - |
dc.contributor.author | Son, Byung Ho | - |
dc.contributor.author | Ahn, Sei Hyun | - |
dc.contributor.author | Lee, Jong Eun | - |
dc.contributor.author | Han, Sun Wook | - |
dc.contributor.author | Kim, Zisun | - |
dc.contributor.author | Hur, Sung Mo | - |
dc.contributor.author | Lee, Ji Sung | - |
dc.contributor.author | Chung, Il Yong | - |
dc.date.accessioned | 2021-08-11T08:37:11Z | - |
dc.date.available | 2021-08-11T08:37:11Z | - |
dc.date.issued | 2020-03-20 | - |
dc.identifier.issn | 2234-943X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2990 | - |
dc.description.abstract | Background: Although international guidelines recommend bone screening for premenopausal breast cancer patients taking adjuvant tamoxifen, the effects of tamoxifen on osteoporosis and related risks remain controversial. The objective of this study was to investigate the incidence of and risk factors for osteoporosis and osteoporotic fractures in younger breast cancer patients. Methods: A nationwide retrospective cohort study was conducted using South Korea Health Insurance Review and Assessment Service claims data. The rates of osteoporosis and osteoporotic fracture were calculated as incident cases per person-year and disease-free probability rates were analyzed with the Kaplan-Meier method. To identify risk factors for osteoporosis and osteoporotic fracture, a multivariable Cox proportional hazard regression model was applied. Results: From January 2009 to December 2014, a total of 47,649 breast cancer patients were included. The incidence rates of osteoporosis and osteoporotic fracture were 23.59 and 2.40 per 1,000 person-years, respectively. In the overall population, tamoxifen was significantly associated with a decreased risk of osteoporosis and osteoporotic fractures 0.76). However, tamoxifen was not associated with the risk of osteoporosis (HR 1.24, CI 0.85-1.82) and osteoporotic fracture (HR 8.15, CI 0.36-186.70) in patients under age 40. In the 40-49 years subgroup, tamoxifen significantly decreased the risk of osteoporosis (HR 0.74, CI 0.65-0.84) and osteoporotic fracture (HR 0.49, CI 0.31-0.76). Conclusions: Tamoxifen is not associated with an increased risk of osteoporosis and osteoporotic fracture in premenopausal breast cancer patients. Tailored screening strategies for breast cancer survivors with different osteoporosis risks are needed. Precis: Tamoxifen is not associated with an increased risk of osteoporosis and osteoporotic fracture in premenopausal breast cancer patients. Tailored screening strategies for breast cancer survivors who are at different risks of developing osteoporosis are needed. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Frontiers Media S.A. | - |
dc.title | Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3389/fonc.2020.00366 | - |
dc.identifier.scopusid | 2-s2.0-85083061772 | - |
dc.identifier.wosid | 000526587800001 | - |
dc.identifier.bibliographicCitation | Frontiers in Oncology, v.10 | - |
dc.citation.title | Frontiers in Oncology | - |
dc.citation.volume | 10 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | BONE-MINERAL DENSITY | - |
dc.subject.keywordPlus | POSTMENOPAUSAL WOMEN | - |
dc.subject.keywordPlus | PREMENOPAUSAL | - |
dc.subject.keywordPlus | ANASTROZOLE | - |
dc.subject.keywordAuthor | breast neoplasms | - |
dc.subject.keywordAuthor | survivorship | - |
dc.subject.keywordAuthor | osteoporosis | - |
dc.subject.keywordAuthor | bone fractures | - |
dc.subject.keywordAuthor | tamoxifen | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.